Mutual Fund Details
NAV
₹12.5990
as on 09 Apr 2020, 11:10 PM
₹0.2490(2.02%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹500
Suggested Date
13th of Every Month
Investment Performance
would have given a return of
₹103,499
₹106,749
₹118,497
₹120,656
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹20,657
Profit (absolute return)
20.66%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
12.00%
In the last 6 months
27.70%
In the last 1 year
20.66%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 09 Apr 2020, 11:10 PM
₹281.24 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 12 months.
0.22%
Expense Ratio
Plan
Growth
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 12 months.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Mar 2020
Healthcare
89.84%
₹252.66 Cr
Financial
4.83%
₹13.58 Cr
Cash Holding
4.56%
₹12.82 Cr
Companies Holding in this Mutual Fund
as on 31 Mar 2020
Ipca Laboratories Ltd.
9.65%
₹27.14 Cr
Dr. Reddy's Laboratories Ltd.
8.87%
₹24.95 Cr
Divi's Laboratories Ltd.
7.55%
₹21.23 Cr
JB Chemicals & Pharmaceuticals Ltd.
7.35%
₹20.67 Cr
Apollo Hospitals Enterprise Ltd.
5.89%
₹16.56 Cr
Indoco Remedies Ltd.
5.40%
₹15.19 Cr
Others
5.33%
₹14.99 Cr
Sun Pharmaceutical Inds. Ltd.
4.42%
₹12.43 Cr
Max India Ltd.
3.66%
₹10.29 Cr
Abbott India Ltd.
3.41%
₹9.59 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Mar 2020
Ipca Laboratories Ltd.
9.65%
₹27.14 Cr
Dr. Reddy's Laboratories Ltd.
8.87%
₹24.95 Cr
Divi's Laboratories Ltd.
7.55%
₹21.23 Cr
JB Chemicals & Pharmaceuticals Ltd.
7.35%
₹20.67 Cr
Apollo Hospitals Enterprise Ltd.
5.89%
₹16.56 Cr
Indoco Remedies Ltd.
5.40%
₹15.19 Cr
Others
5.33%
₹14.99 Cr
Sun Pharmaceutical Inds. Ltd.
4.42%
₹12.43 Cr
Max India Ltd.
3.66%
₹10.29 Cr
Abbott India Ltd.
3.41%
₹9.59 Cr
View All
View All
This fund's returns:
20.66%Return Duration
1 Year
IDBI Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
12.19%
21.98%
1Y Returns
21.98
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
12.19%
21.98%
1Y Returns
19.80
Tata India Pharma & HealthCare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
12.19%
21.98%
1Y Returns
18.12
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
12.19%
21.98%
1Y Returns
15.70
Nippon India Pharma Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
12.19%
21.98%
1Y Returns
13.62
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on 30 Nov 2018 and is currently managed by its fund managers Vinit Sambre and Aditya Khemka. It has an AUM of ₹281.24 Crores and the latest NAV decalared is ₹12.599 as on 09 Apr 2020 at 11:10 pm.
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 20.66%, is 25.31% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹281.24 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 30 Nov 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
AMC Information
DSP Mutual Fund
View AMC Details
₹56,588.95 Cr
AUM
98
Schemes
Address
NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road JunctionWestern Express Highway,Andheri East400069
Phone Number
Phone : 022-66178000
Fax : 022-56578181
Email / Website
